Apixaban in patients with atrial fibrillation and their risk for cardiovascular hospitalization: insights from the AVERROES trial

被引：0
|
作者：
Hohnloser, S. [1 ]
Yusuf, S. [2 ]
Eikelboom, J. [3 ]
Steg, G. [4 ]
Atar, D. [5 ]
Budaj, A. [6 ]
Halon, D. [7 ]
Lau, C. P. [8 ]
Piegas, L. S. [9 ]
Connolly, S. J. [3 ]
机构：
[1] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany
[2] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Hosp Bichat Claude Bernard, AP HP, Dept Cardiol, Paris, France
[5] Oslo Univ Hosp, Oslo, Norway
[6] Grochowski Hosp, Warsaw, Poland
[7] Lady Davis Carmel Med Ctr, Haifa, Israel
[8] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[9] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：671 / 671
页数：1
相关论文
共 50 条
  • [41] Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Wallentin, Lars
    Hijazi, Ziad
    Andersson, Ulrika
    Alexander, John H.
    De Caterina, Raffaele
    Hanna, Michael
    Horowitz, John D.
    Hylek, Elaine M.
    Lopes, Renato D.
    Asberg, Signild
    Granger, Christopher B.
    Siegbahn, Agneta
    [J]. CIRCULATION, 2014, 130 (21) : 1847 - +
  • [42] Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial
    Pokorney, Sean D.
    Chertow, Glenn M.
    Al-Khalidi, Hussein R.
    Gallup, Dianne
    Dignacco, Pat
    Mussina, Kurt
    Bansal, Nisha
    Gadegbeku, Crystal A.
    Garcia, David A.
    Garonzik, Samira
    Lopes, Renato D.
    Mahaffey, Kenneth W.
    Matsuda, Kelly
    Middleton, John P.
    Rymer, Jennifer A.
    Sands, George H.
    Thadhani, Ravi
    Thomas, Kevin L.
    Washam, Jeffrey B.
    Winkelmayer, Wolfgang C.
    Granger, Christopher B.
    [J]. CIRCULATION, 2022, 146 (23) : 1735 - 1745
  • [43] Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial
    Flaker, Greg C.
    Eikelboom, John W.
    Shestakovska, Olga
    Connolly, Stuart J.
    Kaatz, Scott
    Budaj, Andrzej
    Husted, Steen
    Yusuf, Salim
    Lip, Gregory Y. H.
    Hart, Robert G.
    [J]. STROKE, 2012, 43 (12) : 3291 - +
  • [44] Risk factors for recurrent hospitalization of patients with atrial fibrillation
    王雨锋
    [J]. China Medical Abstracts (Internal Medicine), 2020, 37 (03) : 166 - 167
  • [45] Efficacy and safety of apixaban compared with aspirin in patients with atrial fibrillation who previously used and discontinued warfarin therapy: a secondary analysis of the AVERROES trial
    Eikelboom, J.
    Synhorst, D.
    Wright, R.
    Wang, L.
    Afzal, R.
    Yusuf, S.
    Connolly, S. J.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 465 - 465
  • [46] Efficacy and safety of the novel oral factor Xa inhibitor apixaban in atrial fibrillation (AF) patients with chronic kidney disease (CKD): the AVERROES trial
    Hart, R. G.
    Eikelboom, J.
    Yusuf, S.
    Gao, P.
    Paolasso, E.
    De Caterina, R.
    Husted, S.
    Connolly, S. J.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 6 - 6
  • [47] Apixaban Patients with Atrial Fibrillation protective
    Koczorek, Michael
    [J]. ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2012, 150 (03): : 247 - 247
  • [48] Heart rate and death and hospitalization for heart failure in patients with persistent or permanent atrial fibrillation: Insights from the ARISTOTLE trial
    Vinereanu, Dragos
    Wojdyla, Daniel M.
    Alexander, John H.
    Lopes, Renato D.
    Al-Khatib, Sana M.
    Gersh, Bernard J.
    Bahit, M. Cecilia
    Hohnloser, Stefan H.
    Flaker, Greg C.
    Rosenquist, Marten
    Hijazi, Ziad
    Wallentin, Lars
    Granger, Christopher B.
    [J]. AMERICAN HEART JOURNAL, 2023, 265 : 132 - 136
  • [49] Impact of dronedarone on hospitalization for atrial fibrillation: insights from ATHENA
    Page, R. L.
    Crijns, H. J. G. M.
    Connolly, S. J.
    Gaudin, C.
    Van Eickels, M.
    Torp-Petersen, C.
    Hohnloser, S. J.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 450 - 450
  • [50] Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Avezum, Alvaro
    Lopes, Renato D.
    Schulte, Phillip J.
    Lanas, Fernando
    Gersh, Bernard J.
    Hanna, Michael
    Pais, Prem
    Erol, Cetin
    Diaz, Rafael
    Cecilia Bahit, M.
    Bartunek, Jozef
    De Caterina, Raffaele
    Goto, Shinya
    Ruzyllo, Witold
    Zhu, Jun
    Granger, Christopher B.
    Alexander, John H.
    [J]. CIRCULATION, 2015, 132 (08) : 624 - 632
12345